LOGUERCIO, Carmelina
 Distribuzione geografica
Continente #
EU - Europa 14.710
NA - Nord America 7.693
AS - Asia 5.767
SA - Sud America 1.089
AF - Africa 80
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 29.357
Nazione #
RU - Federazione Russa 8.963
US - Stati Uniti d'America 7.565
SG - Singapore 2.188
IE - Irlanda 1.663
CN - Cina 1.101
HK - Hong Kong 1.007
UA - Ucraina 980
BR - Brasile 911
GB - Regno Unito 752
IT - Italia 734
VN - Vietnam 604
DE - Germania 510
FI - Finlandia 326
SE - Svezia 277
TR - Turchia 204
KR - Corea 197
FR - Francia 177
GR - Grecia 162
IN - India 128
JP - Giappone 105
AR - Argentina 66
IQ - Iraq 50
MX - Messico 46
CA - Canada 42
BD - Bangladesh 39
EC - Ecuador 37
NL - Olanda 36
ID - Indonesia 31
BE - Belgio 25
ZA - Sudafrica 24
AT - Austria 23
ES - Italia 18
CL - Cile 16
PL - Polonia 16
PY - Paraguay 16
AU - Australia 15
PK - Pakistan 15
CO - Colombia 14
MA - Marocco 13
DO - Repubblica Dominicana 12
MY - Malesia 10
PE - Perù 10
SA - Arabia Saudita 10
KE - Kenya 9
TN - Tunisia 9
UZ - Uzbekistan 9
VE - Venezuela 9
JM - Giamaica 8
NP - Nepal 8
CZ - Repubblica Ceca 6
IR - Iran 6
MK - Macedonia 6
CH - Svizzera 5
EG - Egitto 5
ET - Etiopia 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
HN - Honduras 4
JO - Giordania 4
LB - Libano 4
LT - Lituania 4
NG - Nigeria 4
PH - Filippine 4
PT - Portogallo 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
CR - Costa Rica 3
GT - Guatemala 3
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
RO - Romania 3
TJ - Tagikistan 3
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
MD - Moldavia 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
EE - Estonia 1
Totale 29.345
Città #
Moscow 3.080
Dublin 1.660
Jacksonville 1.454
Hong Kong 990
Chandler 927
Singapore 826
Santa Clara 722
San Jose 617
Ashburn 303
Princeton 275
Medford 228
Ho Chi Minh City 197
Beijing 177
Seoul 174
Boardman 165
Roxbury 149
San Mateo 132
Ann Arbor 128
Hanoi 128
Wilmington 118
New York 117
Dallas 101
Hefei 101
Woodbridge 88
Naples 83
Bengaluru 80
São Paulo 74
The Dalles 73
Helsinki 71
Caserta 62
Cambridge 61
Los Angeles 58
Des Moines 55
Dong Ket 52
Bremen 47
Munich 46
Nanjing 43
Da Nang 30
Düsseldorf 30
Jinan 29
Haiphong 24
Houston 21
Milan 21
Mountain View 21
Norwalk 21
Tokyo 21
Belo Horizonte 20
Brussels 20
Nuremberg 20
Atlanta 19
Rome 19
Brasília 18
Tianjin 18
Campinas 17
Curitiba 17
Duhok 17
Frankfurt am Main 17
Turku 17
Napoli 16
Orem 16
Rio de Janeiro 16
Shanghai 16
Boydton 15
Guangzhou 15
Kunming 15
Auburn Hills 14
Salvador 14
Venice 14
Council Bluffs 13
Redwood City 13
Thái Bình 13
Bologna 12
Manchester 12
Porto Alegre 12
San Francisco 12
Vienna 12
Amsterdam 11
Baghdad 11
Biên Hòa 11
Chennai 11
Groningen 11
Hangzhou 11
Quito 11
Santiago 11
Goiânia 10
Jinju 10
Memphis 10
Paris 10
Shenyang 10
Zhengzhou 10
Catania 9
Changsha 9
Lanzhou 9
Manaus 9
Mexico City 9
Ninh Bình 9
Santo Domingo 9
St Petersburg 9
São José 9
Tashkent 9
Totale 14.587
Nome #
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 221
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 193
Intrafamilial spread of Helicobacter pylori infection 192
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 186
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 181
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 180
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 179
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 174
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 173
Chronic inflammation and oxidative stress in human carcinogenesis 171
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 170
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 170
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 169
Crohn’s disease and skin 169
A case of hepatotoxicity caused by green tea 166
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 164
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 164
Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease 163
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 162
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 162
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 161
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 160
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 159
Gut-Brain Axis: a new revolution to understand the pathogenesis of autism and other severe neurological diseases 157
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 156
AISF position paper on liver disease and pregnancy 153
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 151
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 150
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 149
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 147
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 146
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 146
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 145
Studio nutrizionale del cirrotico. Confronto fra plicometria cutanea ed acqua corporea 144
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 143
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 143
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system] 143
About gut microbiota: Why? 143
[Early neuropsychological changes in patients with nonalcoholic liver cirrhosis] 143
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 142
[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion] 142
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 141
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 141
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 141
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 140
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 140
Age affects glutathione content and glutathione-transferase activity in human gastric mucosa 139
[Diabetic neuropathy. I). Peripheral neuropathy] 137
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Light alcohol drinking and the risk of cancer development: a controversial relationship 135
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial 133
age aggects glutathione content and glutathione- transferease activity in human gasstric mucosa 133
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 133
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 132
NUTRITIONAL STATUS IN LIVER CIRRHOSIS 131
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 130
Trace elements and chronic liver diseases 129
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 129
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 129
[Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis] 127
Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study 126
[Nutritional problems in cirrhotic patients. Evaluation of dietetic aspects] 124
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 124
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 124
L'alimentazione nel soggetto con epatite virale acuta e cronica 123
Determination of plasma alpha-glutathione-S-transferases in chronic alcohol abusers: relationship with alcohol intake and liver involvement 122
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 122
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 121
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 121
Oxidative stress in viral and alcoholic hepatitis 121
Secrezione salivare e tests strumentali di neuropatia diabetica autonoma 120
Liver p53 expression in patients with HCV-related chronic hepatitis 120
Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol 120
[Gastrin stimulation of salivary secretion: preliminary observations] 120
L'uomo e il vino 120
Gut microbiota and the liver 120
Effetti metabolici della silibina: studi in vitro e in vivo. 119
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 118
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 118
The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients With HCV-Related Chronic Hepatitis. 117
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 117
Aspetti alimentari, stato nutrizionale e malattie dell’apparato digerente – Interazione nell’età evolutiva e nell’adulto 116
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 116
Alterazione della sensibilità gustativa nel diabete mellito 115
Antioxidants in the treatment and prevention of gastric mucosal damage 115
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 114
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. 114
Nutrient intakes, nutritional patterns and the risk of liver cirrhosis: an esplorative case-control study 114
Una spia sulla tavola dei nostri ragazzi 113
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 113
Critical review on the use and abuse of alcohol. When the dose makes the difference 113
Liver failure in an obese middle-aged woman after biliointestinal by pass 112
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years 111
Effect of gastrin upon salivary flow rate in normal subject, duodenal ulcer and cirrhotic patients. 110
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 109
Inhibitory effect of caerulein on salivary secretion in man 109
The significance of alpha-glutathione S transferease determination in patients with chronic liver disease 109
Cirrhosis and frailty assessment in elderly patients: A paradoxical result 109
[Effect of cerulein on human salivary secretion] 108
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study 107
Totale 13.853
Categoria #
all - tutte 103.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 0 0 112
2021/20221.589 142 4 11 48 589 19 31 35 57 52 148 453
2022/20233.277 319 87 34 306 314 262 4 216 1.601 29 53 52
2023/20241.257 119 45 64 126 438 82 45 24 1 19 106 188
2024/20253.659 29 77 56 92 566 347 565 332 442 721 253 179
2025/202614.494 444 499 815 769 1.129 8.452 766 439 627 305 186 63
Totale 29.653